Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
Xin Ye, Dan Huang, Zhixia Dong, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
Kang Wang, Yuecan Zhang, Guangji Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 568-586
Closed Access | Times Cited: 22
Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice
Xin Wang, Yufeng Jin, Can Di, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARα-mediated CYP7A1 activation
Zhenmei Chen, Weiqing Shao, Yitong Li, et al.
Metabolism (2024) Vol. 152, pp. 155774-155774
Closed Access | Times Cited: 7
Gastrointestinal microbiome and cholelithiasis: Current status and perspectives
Wan-Yue Dan, Yun-Sheng Yang, Li-Hua Peng, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 10, pp. 1589-1601
Open Access | Times Cited: 20
Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study
Xutao Hu, Qiu Binxu, Guang-zhao Shao, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Optimization of the cholesterol gallstone model in C57BL/6 mice and evaluation of Lactobacillus intervention effects
Cong Wang, Ting Jiang, L Ye, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
L-Theanine prevents ulcerative colitis by regulating the CD4+ T cell immune response through the gut microbiota and its metabolites
Wei Xu, Ao-Xiang Liu, Zhihua Gong, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109845-109845
Closed Access
Gut microbiome and metabolome characteristics of patients with cholesterol gallstones suggest the preventive potential of prebiotics
Ye Liu, Hexin Li, Tieying Sun, et al.
iMeta (2025)
Open Access
Cost-effectiveness analysis of Pembrolizumab combined with gemcitabine and cisplatin for the first-line treatment for advanced cholangiocarcinoma
Wei Wang, Lijun Xu, Peilin Li, et al.
Heliyon (2025), pp. e42553-e42553
Open Access
Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR–FGF15 signaling pathway
Yong-Fei Zhou, Jiaojiao Nie, Chao Shi, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125725-125725
Closed Access | Times Cited: 14
Gut microbiota causally affects cholelithiasis: a two-sample Mendelian randomization study
Xin Liu, Xingsi Qi, Rongshuang Han, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice
Wei Wang, Kun Zhang, Bin Liu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Dietary silymarin improves performance by altering hepatic lipid metabolism and cecal microbiota function and its metabolites in late laying hens
Guo Yang-hao, Yudong Xu, Derun Wang, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 4
Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor
Linzhang Zhang, Jiewen Shi, Qin Shen, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116833-116833
Closed Access | Times Cited: 11
Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review
Wenquan Su, Yanan Yang, Xiaohui Zhao, et al.
Chinese Herbal Medicines (2023) Vol. 16, Iss. 1, pp. 42-55
Open Access | Times Cited: 9
The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury
Shizhang Wei, Ruilin Wang, Lisheng Chen, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 6, pp. 1134-1144
Closed Access | Times Cited: 2
Gochujang Ameliorates Hepatic Inflammation by Improving Dysbiosis of Gut Microbiota in High-Fat Diet-Induced Obese Mice
Eun-Ji Lee, Olivet Chiamaka Edward, Eun‐Bi Seo, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 911-911
Open Access | Times Cited: 5
Association between gut microbiota and seven gastrointestinal diseases: A Mendelian randomized study
Shuang Jing Zhu, Zhen Ding
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access | Times Cited: 5
Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis
Xu Han, Juan Wang, Yingnan Wu, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305170-e0305170
Open Access | Times Cited: 1
Long-term consumption of different doses of Grifola frondosa affects immunity and metabolism: correlation with intestinal mucosal microbiota and blood lipids
Jing Liu, Yi Wu, Ying Cai, et al.
3 Biotech (2023) Vol. 13, Iss. 6
Closed Access | Times Cited: 4
Environmental inequalities and multimorbidity: Insights from the Southwest China Multi-Ethnic Cohort Study
Qibing Zeng, Jingbo Zhou, Qiong Meng, et al.
The Science of The Total Environment (2023) Vol. 908, pp. 167744-167744
Closed Access | Times Cited: 4
The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
Xiaoyu Huang, Yi Yang, Xueli Li, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Probiotics and liver fibrosis: An evidence-based review of the latest research
Lin Cheng, Jianyou Shi, Haoyuan Peng, et al.
Journal of Functional Foods (2023) Vol. 109, pp. 105773-105773
Open Access | Times Cited: 3
Apple Polyphenol Extract Suppresses Clostridioides difficile Infection in a Mouse Model
Zhengjie Wu, Qiaomai Xu, Ailing Li, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1042-1042
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top